Implantable cardioverter-defibrillators in congenital heart disease

about

Implantable cardioverter-defibrillators in congenital heart disease

Item

http://www.wikidata.org/entity/Q36973794

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Implantable cardioverter-defibrillators in congenital heart disease

@en

type

Item

label

Implantable cardioverter-defibrillators in congenital heart disease

@en

prefLabel

Implantable cardioverter-defibrillators in congenital heart disease

@en

P1476

Implantable cardioverter-defibrillators in congenital heart disease

@en

P2093

E Rosenthal

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study

Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.

Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).

Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.

Effectiveness of excimer laser-assisted pacing and ICD lead extraction in children and young adults.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis

Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population.

Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% s

Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular eje

P2888

s00399-016-0437-3

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00399-016-0437-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henry Chubb

P5008

ScienceSource

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27250725

http://www.w3.org/2001/XMLSchema#string

P921

defibrillator

cardiac arrest

ventricular tachycardia

birth defect

congenital heart disease

P932

4894938

http://www.w3.org/2001/XMLSchema#string

Implantable cardioverter-defibrillators in congenital heart disease

about

Implantable cardioverter-defibrillators in congenital heart disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932